• Explore /
  • Poster
  • / A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).

A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).

Abstract Poster

Authors

null

Marit Ahrens

Medical Clinic II, University Hospital, Frankfurt Am Main, Germany

Marit Ahrens , Bernard Escudier , Ekaterini Boleti , Marc-Oliver Grimm , Marine Gross-Goupil , Philippe Barthelemy , Gwenaelle Gravis , Jens Bedke , Philipp Ivanyi , Andrej Panic , Stefanie Zschaebitz , Sylvie Negrier , Begona Mellado , Anika Biel , Tom Waddell , Pablo Maroto , Margitta Retz , Martin Boegemann , Arndt Hartmann , Lothar Bergmann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03075423

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS5103)

DOI

10.1200/JCO.2020.38.15_suppl.TPS5103

Abstract #

TPS5103

Poster Bd #

172

Abstract Disclosures

Similar Posters

First Author: Marit Ahrens

First Author: Vaibhav Sahai

First Author: Geoffrey Thomas Gibney

First Author: Scott N. Gettinger